Arcus Biosciences, Inc. (RCUS)

Data as of Aug 24, 2026, from SEC Form 4 filings.

XNYSPHARMACEUTICAL PREPARATIONSNet insider selling (90d)Watch RCUS

See up to 3 months of RCUS. The 7-day demo opens the 1M and 3M ranges and puts RCUS on your watchlist.

Latest RCUS insider trades

Alexander Azoy - Officer
Open-market sale$85K
Aug 21, 2026
Juan C. Jaen - Officer
Open-market sale$1.46M

About Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Headquarters: HAYWARD, CA
Employees: 601
Listed: 2018
Exchange: XNYS
Sector: Health Care

https://www.arcusbio.com SEC filings for RCUS on EDGAR

RCUS Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	1	2,827	$85K
Option exercise	2	5,654

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

RCUS insider transactions (Form 4)

46 Form 4 filings on record, the earliest from Dec 4, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Aug 21, 2026	Alexander Azoy - Officer	Option exercise	Common Stock	2,827^{footnote F1}	$15.44	$44K
Aug 21, 2026	Alexander Azoy - Officer	Open-market sale	Common Stock	2,827^{footnote F1}	$30.00	$85K
Aug 21, 2026	Alexander Azoy - Officer	Option exercise	Stock Option (right to buy)	2,827^{footnote F1}	$0.00	-
Footnote F1 (shares): The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Jul 9, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	48,502^{footnote F1}	$30.05^{footnote F2}	$1.46M
Jul 10, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	19,799^{footnote F1}	$28.61^{footnote F3}	$566K
Jul 10, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	268^{footnote F1}	$29.40^{footnote F4}	$8K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 to $29.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Jun 22, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	9,236	$27.03^{footnote F2}	$250K
Jun 23, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	14,067	$27.69^{footnote F3}	$389K
Jun 23, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	1,697	$28.06^{footnote F4}	$48K
Jun 24, 2026	Juan C. Jaen - Officer	Open-market sale	Common Stock	6,431	$29.66^{footnote F5}	$191K
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $28.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.0050 to $28.1550, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.8050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Jun 11, 2026	Nicole Lambert - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Jun 11, 2026	Nicole Lambert - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 11, 2026	Patrick Machado - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Jun 11, 2026	Patrick Machado - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 11, 2026	Yasunori Kaneko - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Jun 11, 2026	Yasunori Kaneko - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 11, 2026	Carolyn C. Tang - Officer	Option exercise	Common Stock	34,090	$2.57	$88K
Jun 11, 2026	Carolyn C. Tang - Officer	Option exercise	Stock Option (Right to Buy)	34,090	$2.57	$88K
Jun 11, 2026	David L. Lacey - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Jun 11, 2026	David L. Lacey - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 11, 2026	Kathryn E. Falberg - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Jun 11, 2026	Kathryn E. Falberg - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 11, 2026	Antoni Ribas - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Jun 11, 2026	Antoni Ribas - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 11, 2026	Andrew J. Perlman - Director	Grant or award	Stock Option (Right to Buy)	16,900	$0.00	-
Jun 11, 2026	Andrew J. Perlman - Director	Grant or award	Common Stock	5,700^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
Jun 1, 2026	Alexander Azoy - Officer	Open-market sale	Common Stock	2,562^{footnote F1,F2}	$25.77^{footnote F3}	$66K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Footnote F2 (shares): Consists of 2,562 shares purchased on 5/29/2026 through the Company's Employee Stock Purchase Plan. Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67 to $25.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Dec 16, 2025	Antoni Ribas - Director	Gift	Common Stock	5,050^{footnote F1}	$0.00	-
Footnote F1 (shares): Gift to family members for estate planning purposes.
May 11, 2026	Ii Robert C. Goeltz - Officer	Open-market sale	Common Stock	7,763^{footnote F1}	$25.63	$199K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Jan 23, 2026	Richard Markus - Officer	Grant or award	Common Stock	24,000^{footnote F1}	$0.00	-
Jan 23, 2026	Richard Markus - Officer	Grant or award	Stock Option (right to buy)	96,000	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Jan 23, 2026	Terry J. Rosen - Officer	Grant or award	Common Stock	79,000^{footnote F1}	$0.00	-
Jan 23, 2026	Terry J. Rosen - Officer	Grant or award	Stock Option (right to buy)	315,000	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Jan 23, 2026	Juan C. Jaen - Officer	Grant or award	Common Stock	31,000^{footnote F1}	$0.00	-
Jan 23, 2026	Juan C. Jaen - Officer	Grant or award	Stock Option (right to buy)	126,000	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Jan 23, 2026	Carolyn C. Tang - Officer	Grant or award	Common Stock	24,000^{footnote F1}	$0.00	-
Jan 23, 2026	Carolyn C. Tang - Officer	Grant or award	Stock Option (right to buy)	96,000	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Jan 23, 2026	Ii Robert C. Goeltz - Officer	Grant or award	Common Stock	24,000^{footnote F1}	$0.00	-
Jan 23, 2026	Ii Robert C. Goeltz - Officer	Grant or award	Stock Option (right to buy)	96,000	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Jan 23, 2026	Alexander Azoy - Officer	Grant or award	Common Stock	21,050^{footnote F1}	$0.00	-
Jan 23, 2026	Alexander Azoy - Officer	Grant or award	Stock Option (right to buy)	14,050	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Jan 23, 2026	Jennifer Jarrett - Officer	Grant or award	Common Stock	31,000^{footnote F1}	$0.00	-
Jan 23, 2026	Jennifer Jarrett - Officer	Grant or award	Stock Option (right to buy)	126,000	$0.00	-
Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Dec 31, 2025	Ii Robert C. Goeltz - Officer	Open-market sale	Common Stock	6,552	$23.38	$153K
Dec 30, 2025	Terry J. Rosen - Officer	Gift	Common Stock	2,400	$0.00	-
Dec 4, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	82,997^{footnote F1}	$24.71^{footnote F2}	$2.05M
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025. Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Nov 26, 2025	Alexander Azoy - Officer	Option exercise	Common Stock	1,900^{footnote F1}	$13.33	$25K
Nov 26, 2025	Alexander Azoy - Officer	Open-market sale	Common Stock	1,900^{footnote F1}	$26.00	$49K
Nov 26, 2025	Alexander Azoy - Officer	Option exercise	Stock Option (right to buy)	1,900^{footnote F1}	$0.00	-
Footnote F1 (shares): The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Nov 26, 2025	Ii Robert C. Goeltz - Officer	Open-market sale	Common Stock	5,000^{footnote F1}	$25.00	$125K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Nov 18, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	5,050^{footnote F1}	$19.75^{footnote F4}	$100K
Nov 17, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	37,114^{footnote F1}	$20.23^{footnote F2}	$751K
Nov 17, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	7,836^{footnote F1}	$20.71^{footnote F3}	$162K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025. Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Nov 7, 2025	Jennifer Jarrett - Officer	Option exercise	Common Stock	50,291^{footnote F1}	$1.23	$62K
Nov 7, 2025	Jennifer Jarrett - Officer	Open-market sale	Common Stock	50,291^{footnote F1}	$18.97^{footnote F2}	$954K
Nov 7, 2025	Jennifer Jarrett - Officer	Option exercise	Stock Option (Right to Buy)	50,291	$1.23	$62K
Footnote F1 (shares): The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.59 to $19.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Oct 30, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	4,314^{footnote F1}	$20.32^{footnote F2}	$88K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Oct 29, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	47,675^{footnote F1}	$20.49^{footnote F3}	$977K
Oct 29, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	29,365^{footnote F1}	$21.53^{footnote F4}	$632K
Oct 29, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	800^{footnote F1}	$22.04^{footnote F5}	$18K
Oct 28, 2025	Juan C. Jaen - Officer	Open-market sale	Common Stock	19,019^{footnote F1}	$20.19^{footnote F2}	$384K
Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.02 to $22.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.035 to $22.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Recent RCUS Form 8-K filings

Read RCUS company news

Aug 5, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jun 12, 2026Item 5.07

Read the filing on SEC EDGAR

May 5, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Apr 20, 2026Item 8.01

Read the filing on SEC EDGAR

Recent RCUS Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Aug 21, 2026	ALEXANDER AZOY	Officer	2,827	$83K	View on EDGAR
Jul 9, 2026	-	-	-	-

RCUS insider trading FAQ

What is the latest insider trade for RCUS?

Arcus Biosciences, Inc. (RCUS) had 1 insider filing in the last 90 days, with the most recent on 2026-08-24. The full record for RCUS runs to 46 Form 4 filings, the earliest from 2024-12-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying RCUS stock?

No insider purchases of RCUS were filed in the last 90 days.

How many insiders are selling RCUS stock?

1 insider sale of RCUS was filed in the last 90 days, totaling $85K.

Where can I see RCUS SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects RCUS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Aug 24, 2026 - Alexander Azoy view on EDGAR
Jul 13, 2026 - Juan C. Jaen view on EDGAR
Jun 24, 2026 - Juan C. Jaen view on EDGAR
Jun 12, 2026 - Nicole Lambert view on EDGAR
Jun 12, 2026 - Patrick Machado view on EDGAR
Jun 12, 2026 - Yasunori Kaneko view on EDGAR
Jun 12, 2026 - Carolyn C. Tang view on EDGAR
Jun 12, 2026 - David L. Lacey view on EDGAR
Jun 12, 2026 - Kathryn E. Falberg view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where RCUS's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow RCUS with a 7-day demo

RCUS on your watchlist
Every RCUS Form 4 filing on record
Up to 3 months of RCUS price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

2,827

$85K

Option exercise

5,654

Date

Insider

Transaction

Security

Price

Value

Aug 21, 2026

Alexander Azoy - Officer

Option exercise

Common Stock

2,827^{footnote F1}

$15.44

$44K

Aug 21, 2026

Alexander Azoy - Officer

Open-market sale

Common Stock

2,827^{footnote F1}

$30.00

$85K

Aug 21, 2026

Alexander Azoy - Officer

Option exercise

Stock Option (right to buy)

2,827^{footnote F1}

$0.00

Footnote F1 (shares): The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Jul 9, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

48,502^{footnote F1}

$30.05^{footnote F2}

$1.46M

Jul 10, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

19,799^{footnote F1}

$28.61^{footnote F3}

$566K

Jul 10, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

268^{footnote F1}

$29.40^{footnote F4}

$8K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 to $29.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Jun 22, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

9,236

$27.03^{footnote F2}

$250K

Jun 23, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

14,067

$27.69^{footnote F3}

$389K

Jun 23, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

1,697

$28.06^{footnote F4}

$48K

Jun 24, 2026

Juan C. Jaen - Officer

Open-market sale

Common Stock

6,431

$29.66^{footnote F5}

$191K

Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $28.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.0050 to $28.1550, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.8050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Jun 11, 2026

Nicole Lambert - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Jun 11, 2026

Nicole Lambert - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 11, 2026

Patrick Machado - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Jun 11, 2026

Patrick Machado - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 11, 2026

Yasunori Kaneko - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Jun 11, 2026

Yasunori Kaneko - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 11, 2026

Carolyn C. Tang - Officer

Option exercise

Common Stock

34,090

$2.57

$88K

Jun 11, 2026

Carolyn C. Tang - Officer

Option exercise

Stock Option (Right to Buy)

34,090

$2.57

$88K

Jun 11, 2026

David L. Lacey - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Jun 11, 2026

David L. Lacey - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 11, 2026

Kathryn E. Falberg - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Jun 11, 2026

Kathryn E. Falberg - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 11, 2026

Antoni Ribas - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Jun 11, 2026

Antoni Ribas - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 11, 2026

Andrew J. Perlman - Director

Grant or award

Stock Option (Right to Buy)

16,900

$0.00

Jun 11, 2026

Andrew J. Perlman - Director

Grant or award

Common Stock

5,700^{footnote F1}

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

Jun 1, 2026

Alexander Azoy - Officer

Open-market sale

Common Stock

2,562^{footnote F1,F2}

$25.77^{footnote F3}

$66K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2 (shares): Consists of 2,562 shares purchased on 5/29/2026 through the Company's Employee Stock Purchase Plan.
Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67 to $25.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Dec 16, 2025

Antoni Ribas - Director

Gift

Common Stock

5,050^{footnote F1}

$0.00

Footnote F1 (shares): Gift to family members for estate planning purposes.

May 11, 2026

Ii Robert C. Goeltz - Officer

Open-market sale

Common Stock

7,763^{footnote F1}

$25.63

$199K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Jan 23, 2026

Richard Markus - Officer

Grant or award

Common Stock

24,000^{footnote F1}

$0.00

Jan 23, 2026

Richard Markus - Officer

Grant or award

Stock Option (right to buy)

96,000

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Jan 23, 2026

Terry J. Rosen - Officer

Grant or award

Common Stock

79,000^{footnote F1}

$0.00

Jan 23, 2026

Terry J. Rosen - Officer

Grant or award

Stock Option (right to buy)

315,000

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Jan 23, 2026

Juan C. Jaen - Officer

Grant or award

Common Stock

31,000^{footnote F1}

$0.00

Jan 23, 2026

Juan C. Jaen - Officer

Grant or award

Stock Option (right to buy)

126,000

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Jan 23, 2026

Carolyn C. Tang - Officer

Grant or award

Common Stock

24,000^{footnote F1}

$0.00

Jan 23, 2026

Carolyn C. Tang - Officer

Grant or award

Stock Option (right to buy)

96,000

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Jan 23, 2026

Ii Robert C. Goeltz - Officer

Grant or award

Common Stock

24,000^{footnote F1}

$0.00

Jan 23, 2026

Ii Robert C. Goeltz - Officer

Grant or award

Stock Option (right to buy)

96,000

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Jan 23, 2026

Alexander Azoy - Officer

Grant or award

Common Stock

21,050^{footnote F1}

$0.00

Jan 23, 2026

Alexander Azoy - Officer

Grant or award

Stock Option (right to buy)

14,050

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Jan 23, 2026

Jennifer Jarrett - Officer

Grant or award

Common Stock

31,000^{footnote F1}

$0.00

Jan 23, 2026

Jennifer Jarrett - Officer

Grant or award

Stock Option (right to buy)

126,000

$0.00

Footnote F1 (shares): Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.

Dec 31, 2025

Ii Robert C. Goeltz - Officer

Open-market sale

Common Stock

6,552

$23.38

$153K

Dec 30, 2025

Terry J. Rosen - Officer

Gift

Common Stock

2,400

$0.00

Dec 4, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

82,997^{footnote F1}

$24.71^{footnote F2}

$2.05M

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025.
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Nov 26, 2025

Alexander Azoy - Officer

Option exercise

Common Stock

1,900^{footnote F1}

$13.33

$25K

Nov 26, 2025

Alexander Azoy - Officer

Open-market sale

Common Stock

1,900^{footnote F1}

$26.00

$49K

Nov 26, 2025

Alexander Azoy - Officer

Option exercise

Stock Option (right to buy)

1,900^{footnote F1}

$0.00

Footnote F1 (shares): The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Nov 26, 2025

Ii Robert C. Goeltz - Officer

Open-market sale

Common Stock

5,000^{footnote F1}

$25.00

$125K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Nov 18, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

5,050^{footnote F1}

$19.75^{footnote F4}

$100K

Nov 17, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

37,114^{footnote F1}

$20.23^{footnote F2}

$751K

Nov 17, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

7,836^{footnote F1}

$20.71^{footnote F3}

$162K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Nov 7, 2025

Jennifer Jarrett - Officer

Option exercise

Common Stock

50,291^{footnote F1}

$1.23

$62K

Nov 7, 2025

Jennifer Jarrett - Officer

Open-market sale

Common Stock

50,291^{footnote F1}

$18.97^{footnote F2}

$954K

Nov 7, 2025

Jennifer Jarrett - Officer

Option exercise

Stock Option (Right to Buy)

50,291

$1.23

$62K

Footnote F1 (shares): The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.59 to $19.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Oct 30, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

4,314^{footnote F1}

$20.32^{footnote F2}

$88K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Oct 29, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

47,675^{footnote F1}

$20.49^{footnote F3}

$977K

Oct 29, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

29,365^{footnote F1}

$21.53^{footnote F4}

$632K

Oct 29, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

800^{footnote F1}

$22.04^{footnote F5}

$18K

Oct 28, 2025

Juan C. Jaen - Officer

Open-market sale

Common Stock

19,019^{footnote F1}

$20.19^{footnote F2}

$384K

Footnote F1 (shares): The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024.
Footnote F2 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.02 to $22.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.035 to $22.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Filed

Filer

Relationship

Market value

Notice

Aug 21, 2026

ALEXANDER AZOY

Officer

2,827

$83K

View on EDGAR

Jul 9, 2026